» Articles » PMID: 14531730

WBP-2, a WW Domain Binding Protein, Interacts with the Thyroid-specific Transcription Factor Pax8

Overview
Journal Biochem J
Specialty Biochemistry
Date 2003 Oct 9
PMID 14531730
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The Pax gene family encodes transcription factors that are essential in organogenesis and in the differentiation of various organs in higher eukaryotes. Pax proteins have a DNA binding domain at the N-terminus, and a transcriptional activation domain at the C-terminus. How these domains interact with the transcriptional machinery of the cell is still unclear. In the present paper, we describe the identification by means of immunological screening of the WW domain binding protein WBP-2 as a biochemical interactor of Pax8 (a WW domain is a protein-interaction domain containing two conserved tryptophan residues). Pax8 is required for the morphogenesis of the thyroid gland and for the maintenance of the thyroid differentiated cellular phenotype. WBP-2 was identified originally as a WW domain binding protein, and its function is still unknown. WBP-2 binds to Pax8 in vitro in pulldown assays, and in vivo in tissue culture cells in co-immunoprecipitation assays. Interestingly, Pax8 does not contain a WW domain. Our results point to the identification of a new protein-interacting domain that is present in the C-terminal portion of Pax8 and that is required for protein-protein interaction with WBP-2. Our results demonstrate that WBP-2 is not a transcriptional co-activator of Pax8, but rather behaves as an adaptor molecule, as suggested in other studies.

Citing Articles

WW domain binding protein 2 (WBP2) as an oncogene in breast cancer: mechanisms and therapeutic prospects-a narrative review.

Liu Y, He E, Zhang Y, Liu Y, Wang Y, Chen S Gland Surg. 2023; 11(12):1984-2002.

PMID: 36654949 PMC: 9841001. DOI: 10.21037/gs-22-716.


WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression.

Han Q, Rong X, Lin X, Zhang X, Fan C, Zhao H Cell Death Dis. 2021; 12(4):384.

PMID: 33837178 PMC: 8035140. DOI: 10.1038/s41419-021-03600-3.


WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1.

Zheng Z, Li Y, Fan S, An J, Luo X, Liang M Cell Death Dis. 2021; 12(3):228.

PMID: 33658485 PMC: 7930037. DOI: 10.1038/s41419-021-03536-8.


The emerging roles of WBP2 oncogene in human cancers.

Tabatabaeian H, Rao A, Ramos A, Chu T, Sudol M, Lim Y Oncogene. 2020; 39(24):4621-4635.

PMID: 32393834 PMC: 7286818. DOI: 10.1038/s41388-020-1318-0.


The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK/Jun kinase pathway.

Li Z, Lim S, Liang X, Lim Y J Biol Chem. 2018; 293(52):20014-20028.

PMID: 30442712 PMC: 6311518. DOI: 10.1074/jbc.RA118.005796.


References
1.
Muchardt C, Yaniv M . ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job. J Mol Biol. 1999; 293(2):187-98. DOI: 10.1006/jmbi.1999.2999. View

2.
Bachurski C, Yan C, Whitsett J . Regulation of mouse SP-B gene promoter by AP-1 family members. Am J Physiol. 1999; 277(1):L79-88. DOI: 10.1152/ajplung.1999.277.1.L79. View

3.
Damante G, Tell G, Di Lauro R . A unique combination of transcription factors controls differentiation of thyroid cells. Prog Nucleic Acid Res Mol Biol. 2000; 66:307-56. DOI: 10.1016/s0079-6603(00)66033-6. View

4.
Pasca di Magliano M, Di Lauro R, Zannini M . Pax8 has a key role in thyroid cell differentiation. Proc Natl Acad Sci U S A. 2000; 97(24):13144-9. PMC: 27192. DOI: 10.1073/pnas.240336397. View

5.
Yang Y, Yang M, Wang B, Weissler J . BR22, a novel protein, interacts with thyroid transcription factor-1 and activates the human surfactant protein B promoter. Am J Respir Cell Mol Biol. 2001; 24(1):30-37. DOI: 10.1165/ajrcmb.24.1.4050. View